Hypoxic Culture Maintains Cell Growth of the Primary Human Valve Interstitial Cells with Stemness.
aortic valve
hypoxia
interstitial cells
oxidative stress
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
29 Sep 2021
29 Sep 2021
Historique:
received:
31
08
2021
revised:
17
09
2021
accepted:
26
09
2021
entrez:
13
10
2021
pubmed:
14
10
2021
medline:
28
10
2021
Statut:
epublish
Résumé
The characterization of aortic valve interstitial cells (VICs) cultured under optimal conditions is essential for understanding the molecular mechanisms underlying aortic valve stenosis. Here, we propose 2% hypoxia as an optimum VIC culture condition. Leaflets harvested from patients with aortic valve regurgitation were digested using collagenase and VICs were cultured under the 2% hypoxic condition. A significant increase in VIC growth was observed in 2% hypoxia (hypo-VICs), compared to normoxia (normo-VICs). RNA-sequencing revealed that downregulation of oxidative stress-marker genes (such as superoxide dismutase) and upregulation of cell cycle accelerators (such as cyclins) occurred in hypo-VICs. Accumulation of reactive oxygen species was observed in normo-VICs, indicating that low oxygen tension can avoid oxidative stress with cell-cycle arrest. Further mRNA quantifications revealed significant upregulation of several mesenchymal and hematopoietic progenitor markers, including CD34, in hypo-VICs. The stemness of hypo-VICs was confirmed using osteoblast differentiation assays, indicating that hypoxic culture is beneficial for maintaining growth and stemness, as well as for avoiding senescence via oxidative stress. The availability of hypoxic culture was also demonstrated in the molecular screening using proteomics. Therefore, hypoxic culture can be helpful for the identification of therapeutic targets and the evaluation of VIC molecular functions in vitro.
Identifiants
pubmed: 34638873
pii: ijms221910534
doi: 10.3390/ijms221910534
pmc: PMC8508607
pii:
doi:
Substances chimiques
Antigens, CD34
0
RNA, Messenger
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Ministry of Education, Culture, Sports, Science and Technology
ID : 18K16396, 16K10631, 19H03740, 19K17603, 19K08585, and 16K109503
Organisme : Public Trust Cardiovascular Research Foundation
ID : 2017
Organisme : Takeda Science Foundation
ID : 2016 and 2020
Organisme : SENSHIN Medical Research Foundation
ID : 2016 and 2020
Organisme : MSD Life Science Foundation, Public Interest Incorporated Foundation
ID : 2016
Références
Biochem Biophys Res Commun. 2013 Nov 1;440(4):780-5
pubmed: 24120498
Exp Cell Res. 2011 Jul 1;317(11):1541-7
pubmed: 21376036
Bone. 1992;13(1):81-8
pubmed: 1581112
J Cell Physiol. 2006 Jul;208(1):64-76
pubmed: 16557516
J Cell Mol Med. 2014 Jan;18(1):104-14
pubmed: 24188055
Cell Commun Signal. 2020 Nov 30;18(1):188
pubmed: 33256735
J Mol Cell Cardiol. 2009 Dec;47(6):828-34
pubmed: 19695258
Cell Transplant. 2010;19(3):279-89
pubmed: 19995482
Circ Res. 2008 Jan 4;102(1):77-85
pubmed: 17967785
Biochem Biophys Res Commun. 2004 Jan 30;314(1):197-207
pubmed: 14715266
Biophys J. 2001 Aug;81(2):675-84
pubmed: 11463616
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
Ann Thorac Surg. 2020 Jul;110(1):40-49
pubmed: 31760051
Int J Mol Sci. 2020 Aug 31;21(17):
pubmed: 32878299
Circulation. 2001 Mar 20;103(11):1522-8
pubmed: 11257079
Tumour Biol. 2016 Sep;37(9):11611-11622
pubmed: 27337957
Cell Prolif. 2012 Jun;45(3):225-38
pubmed: 22507457
Am J Pathol. 2009 Mar;174(3):1109-19
pubmed: 19218344
Surgery. 2017 Jun;161(6):1525-1535
pubmed: 28143660
Am J Transl Res. 2017 Mar 15;9(3):1521-1529
pubmed: 28386377
Arterioscler Thromb Vasc Biol. 2014 Nov;34(11):2387-93
pubmed: 25189570
Int Heart J. 2016;57(1):104-11
pubmed: 26742884
Science. 1999 Apr 2;284(5411):143-7
pubmed: 10102814
Cytotherapy. 2008;10(3):243-53
pubmed: 18418770
Cell Tissue Res. 2003 Feb;311(2):227-37
pubmed: 12596042
Trends Mol Med. 2018 Oct;24(10):871-885
pubmed: 30153969
Cardiovasc Pathol. 2016 Jan-Feb;25(1):18-24
pubmed: 26386747
Blood. 2011 Jan 13;117(2):459-69
pubmed: 20952688
PLoS One. 2015 Oct 14;10(10):e0139890
pubmed: 26465938
Stem Cells. 2006 Apr;24(4):928-35
pubmed: 16306150
J Dermatol Sci. 2016 May;82(2):84-94
pubmed: 26867959
PLoS One. 2013;8(3):e59354
pubmed: 23555021
J Cell Mol Med. 2014 May;18(5):759-65
pubmed: 24674389
Biophys J. 2001 Aug;81(2):685-96
pubmed: 11463617
Lancet. 2006 Sep 16;368(9540):1005-11
pubmed: 16980116
Circulation. 2003 May 6;107(17):2181-4
pubmed: 12719282
Biomed Pharmacother. 2018 Sep;105:1-9
pubmed: 29807229
Front Cardiovasc Med. 2018 Mar 26;5:27
pubmed: 29632866
Front Cardiovasc Med. 2021 Apr 23;8:639740
pubmed: 33969008
Free Radic Biol Med. 2001 Aug 15;31(4):509-19
pubmed: 11498284
J Proteome Res. 2012 Mar 2;11(3):1537-50
pubmed: 22276806